John Frederick
Director at Tempest Therapeutics.
- Brisbane, CA
- Tempest Therapeutics
Raised on Tempest Therapeutics filings
$13.6M
of $13.6M offered across 3 Form D filings
- Form D filings
- 3
- Teammates
- 3
- Last filing
- Oct 13, 2026
Company
In vivo CAR-T therapies for autoimmune disease and cancer
- Investors
- 3
Tempest Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Oct 13, 2026 | Security to be acquired | $7.5M/ $7.5M | Form D |
| Jun 23, 2026 | Equity | $4.1M/ $4.1M | Form D |
| Apr 3, 2026 | Equity | $2M/ $2M | Form D |
